August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Language matters when interacting with patients who have conditions such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and dysautonomia.

Personal independence payment claims for anxiety and depression have more than doubled since 2019, official statistics show ...